Table 3 Number of adverse events within 90 days after primary total hip replacement (THR) among propensity score matched patients who were eligible for red blood cell transfusion.
| Â | Propensity score matching model | |
|---|---|---|
Outcome | Transfusion n = 2,254 | Non-transfusion n = 2,254 |
Death | 39 (1.7%) | 18 (0.8%) |
Cardiovascular or cerebrovascular disease | 54 (2.4%) | 39 (1.7%) |
Deep venous thrombosis and/or pulmonary embolism | 28 (1.2%) | 23 (1.0%) |
Pneumonia | 36 (1.6%) | 17 (0.8%) |
Reoperation due to Infection of THR | 5 (0.2%) | 5 (0.2%) |